Skip to content
Home » Plus Therapeutics Trialing Cancer Treatment for Cerebrospinal Fluid

Plus Therapeutics Trialing Cancer Treatment for Cerebrospinal Fluid

    By Karen E. Roman Plus Therapeutics, Inc. (Nasdaq: PSTV) announced treatment of the first patient in Part B of a trial for the treatment of leptomeningeal metastases from solid tumors. Leptomeningeal metastases are complication of cancer in which the primary cancer spreads to the cerebrospinal fluid. Data from a clinical study showed 10 patients were treated and cerebrospinal […]

    Read full NASCAR article on Yahoo Sports

    Read all NASCAR articles